December 24, 2013 — Clinical trials for a promising new class of cholesterol-lowering medications, a long-awaited repair ...
Renal Denervation
This channel includes news and new technology innovations for renal denervation used to treat hypertension. Renal denervation is a catheter-based therapy. The catheter is into the renal artery and delivers radio-frequency energy to ablate the nerves in the vessel wall that regulate vasoconstriction. This leaves the vessel permanently in the widest open position to allow greater blood flow to the kidneys. This enables greater filtration of the blood and removal of excess water that causes hypertension.
December 6, 2013 — Medtronic Inc. announced CE mark in Europe and Therapeutic Goods Administration (TGA) listing in ...
December 06, 2013
December 6, 2013 – Medtronic, Inc. presented three-year data from SYMPLICITY HTN-2, the first and longest-running ...
December 06, 2013November 13, 2013 — Petr Neuzil, M.D., Nemocnice Na Homolce Hospital, Prague, Czech Republic, presented three-month ...
November 13, 2013
November 13, 2013 — Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an ...
November 13, 2013
October 31, 2013 — Patients treated with the Boston Scientific Vessix Renal Denervation System experienced a significant ...
October 31, 2013October 28, 2013 — CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education ...
October 28, 2013
October 25, 2013 — Kona Medical Inc. announced it has closed a Series D equity financing of $10 million. Morningside ...
October 25, 2013
October 14, 2013 — Since its debut in 2010, the renal denervation market has generated enthusiasm across the medical ...
October 14, 2013
September 3, 2013 — St. Jude Medical Inc. announced the CE mark approval of its next-generation EnligHTN renal ...
September 03, 2013
August 22, 2013 — Qinghui Chen, assistant professor in Michigan Tech’s kinesiology and integrative physiology department ...
August 22, 2013
August 2, 2013 — Mercator MedSystems has been issued U.S. Patent 8,465,752, which protects the company’s sole U.S ...
August 02, 2013
Feature | Dave Fornell
One of the exciting new frontiers for interventional cardiology is the use of renal denervation therapy to treat ...
July 30, 2013
Feature | Anita Asgar, M.D., FSCAI
The field of interventional cardiology is one of constant change and innovation. The past 10 years have documented ...
July 03, 2013June 13, 2013 — St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval to begin the EnligHTN ...
June 13, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now